vs
Side-by-side financial comparison of Ivanhoe Electric Inc. (IE) and RELMADA THERAPEUTICS, INC. (RLMD). Click either name above to swap in a different company.
RELMADA THERAPEUTICS, INC. is the larger business by last-quarter revenue ($1.3M vs $896.0K, roughly 1.4× Ivanhoe Electric Inc.). On growth, RELMADA THERAPEUTICS, INC. posted the faster year-over-year revenue change (13.0% vs -32.7%). Over the past eight quarters, RELMADA THERAPEUTICS, INC.'s revenue compounded faster (95.4% CAGR vs 57.8%).
Ivanhoe Electric Inc. is a critical minerals exploration and development firm focused on metals for global electrification. It targets high-grade copper, gold, silver and strategic deposits, with primary North American operations, supplying raw materials to renewable energy, EV and power grid infrastructure supply chains worldwide.
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies for central nervous system disorders. Its lead product candidate targets treatment-resistant depression, with ongoing clinical trials to address unmet medical needs in its primary markets of North America and Europe.
IE vs RLMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $896.0K | $1.3M |
| Net Profit | $-40.3M | — |
| Gross Margin | 69.5% | — |
| Operating Margin | -4167.7% | -2130.6% |
| Net Margin | -4500.4% | — |
| Revenue YoY | -32.7% | 13.0% |
| Net Profit YoY | -318.3% | — |
| EPS (diluted) | $0.24 | $-0.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $896.0K | — | ||
| Q3 25 | $545.0K | — | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $735.0K | — | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $671.0K | — | ||
| Q2 24 | $538.0K | — | ||
| Q1 24 | $360.0K | — |
| Q4 25 | $-40.3M | — | ||
| Q3 25 | $-17.5M | — | ||
| Q2 25 | $-23.9M | — | ||
| Q1 25 | $-34.1M | — | ||
| Q4 24 | $18.5M | — | ||
| Q3 24 | $-43.2M | — | ||
| Q2 24 | $-46.8M | — | ||
| Q1 24 | $-60.1M | — |
| Q4 25 | 69.5% | — | ||
| Q3 25 | 51.2% | — | ||
| Q2 25 | 72.5% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 64.7% | — | ||
| Q3 24 | 61.8% | — | ||
| Q2 24 | 64.3% | — | ||
| Q1 24 | 72.2% | — |
| Q4 25 | -4167.7% | — | ||
| Q3 25 | -4328.3% | — | ||
| Q2 25 | -2400.3% | — | ||
| Q1 25 | -3674.0% | — | ||
| Q4 24 | -2229.4% | — | ||
| Q3 24 | -6233.8% | — | ||
| Q2 24 | -9023.4% | — | ||
| Q1 24 | -15800.3% | — |
| Q4 25 | -4500.4% | — | ||
| Q3 25 | -3214.9% | — | ||
| Q2 25 | -2233.2% | — | ||
| Q1 25 | -4645.0% | — | ||
| Q4 24 | 1386.6% | — | ||
| Q3 24 | -6443.5% | — | ||
| Q2 24 | -8695.7% | — | ||
| Q1 24 | -16693.1% | — |
| Q4 25 | $0.24 | — | ||
| Q3 25 | $0.13 | — | ||
| Q2 25 | $0.18 | — | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.36 | — | ||
| Q2 24 | $0.39 | — | ||
| Q1 24 | $0.46 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $173.3M | $96.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $416.1M | $85.4M |
| Total Assets | $483.3M | $97.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $173.3M | — | ||
| Q3 25 | $69.5M | — | ||
| Q2 25 | $88.0M | — | ||
| Q1 25 | $98.2M | — | ||
| Q4 24 | $41.0M | — | ||
| Q3 24 | $81.1M | — | ||
| Q2 24 | $133.8M | — | ||
| Q1 24 | $179.4M | — |
| Q4 25 | $416.1M | — | ||
| Q3 25 | $280.1M | — | ||
| Q2 25 | $293.3M | — | ||
| Q1 25 | $307.0M | — | ||
| Q4 24 | $268.6M | — | ||
| Q3 24 | $250.1M | — | ||
| Q2 24 | $289.2M | — | ||
| Q1 24 | $331.5M | — |
| Q4 25 | $483.3M | — | ||
| Q3 25 | $386.2M | — | ||
| Q2 25 | $400.5M | — | ||
| Q1 25 | $414.4M | — | ||
| Q4 24 | $374.9M | — | ||
| Q3 24 | $375.4M | — | ||
| Q2 24 | $416.3M | — | ||
| Q1 24 | $461.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $-10.2M |
| Free Cash FlowOCF − Capex | $-25.7M | — |
| FCF MarginFCF / Revenue | -2872.8% | — |
| Capex IntensityCapex / Revenue | 4.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-90.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.7M | — | ||
| Q3 25 | $-27.7M | — | ||
| Q2 25 | $-20.0M | — | ||
| Q1 25 | $-15.8M | — | ||
| Q4 24 | $-30.7M | — | ||
| Q3 24 | $-36.9M | — | ||
| Q2 24 | $-44.5M | — | ||
| Q1 24 | $-50.0M | — |
| Q4 25 | $-25.7M | — | ||
| Q3 25 | $-27.8M | — | ||
| Q2 25 | $-21.3M | — | ||
| Q1 25 | $-15.8M | — | ||
| Q4 24 | $-32.4M | — | ||
| Q3 24 | $-36.9M | — | ||
| Q2 24 | $-45.0M | — | ||
| Q1 24 | $-50.6M | — |
| Q4 25 | -2872.8% | — | ||
| Q3 25 | -5103.9% | — | ||
| Q2 25 | -1990.1% | — | ||
| Q1 25 | -2146.5% | — | ||
| Q4 24 | -2432.4% | — | ||
| Q3 24 | -5506.6% | — | ||
| Q2 24 | -8372.9% | — | ||
| Q1 24 | -14064.2% | — |
| Q4 25 | 4.1% | — | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 117.6% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 127.3% | — | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 93.7% | — | ||
| Q1 24 | 186.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -1.66× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
